Tormene Daniela, Gavasso Sabrina, Rossetto Valeria, Simioni Paolo
Department of Medical and Surgical Sciences, University of Padua Medical School, Padua, Italy.
Semin Thromb Hemost. 2006 Oct;32(7):724-8. doi: 10.1055/s-2006-951457.
Thrombotic events are uncommon disorders in childhood but increasingly recognized due to the progress made in the understanding of the hemostasis system and the importance of thromboembolic disorders in children. Multiple clinical underlying conditions and prothrombotic disorders contribute to the development of thrombosis in neonates and children. In recent years programs have emerged that specialize in the diagnosis, prevention, and treatment of thrombosis in children. This review summarizes the current knowledge of the risk factors for thromboembolic events in the venous and arterial systems in children, the use of antithrombotic prophylaxis, and the role of thrombophilia. First, the clinical manifestations and the problems of diagnosing venous thromboembolic diseases and cerebrovascular diseases in children are reviewed. The prophylactic use of anticoagulants in children is also discussed. Unfortunately there are no large prospective randomized trials in children, thus guidelines are based on small studies or on extrapolation of data from adults. Second, the impact of prothrombotic defects in pediatric patients and the issue of routine testing for these disturbances are reviewed.
血栓形成事件在儿童期是罕见的疾病,但由于在止血系统理解方面取得的进展以及儿童血栓栓塞性疾病的重要性,其越来越受到认可。多种临床基础疾病和血栓前状态导致新生儿和儿童发生血栓形成。近年来,出现了专门针对儿童血栓形成的诊断、预防和治疗的项目。本综述总结了目前关于儿童静脉和动脉系统血栓栓塞事件的危险因素、抗血栓预防措施的使用以及易栓症作用的知识。首先,回顾了儿童静脉血栓栓塞性疾病和脑血管疾病的临床表现及诊断问题。还讨论了儿童抗凝剂的预防性使用。遗憾的是,儿童中没有大型前瞻性随机试验,因此指南基于小型研究或从成人数据外推得出。其次,回顾了儿科患者血栓前缺陷的影响以及这些紊乱的常规检测问题。